Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
1.
Curr Opin Pulm Med ; 7(6): 386-90, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11706313

ABSTRACT

Patients with sleep apnea may be at increased risk for cardiovascular disease. Recently, the link between hypertension and sleep apnea has been strengthened by findings of two large epidemiologic studies. Neurohumoral and hemodynamic responses to repetitive episodes of hypoxemia and apnea may offer a pathophysiologic basis for patients with sleep apnea having an increased risk for hypertension. Sympathetic, humoral, and cellular responses to sleep apnea over the long term may cause vascular dysfunction and consequent hypertension. These responses may be exacerbated by sleep deprivation, which occurs commonly in patients with sleep apnea because of poor sleep architecture. Patients with sleep apnea are often obese and may be predisposed to weight gain. Hence, obesity may further contribute to cardiovascular risk in this patient population. Alleviation of sleep disordered breathing may be accompanied by lower blood pressure in hypertensive patients with sleep apnea.


Subject(s)
Hypertension/etiology , Sleep Apnea Syndromes/complications , Humans , Hypertension/physiopathology , Obesity/complications , Risk Factors , Sleep Apnea Syndromes/physiopathology , Sleep Apnea Syndromes/therapy
2.
Am J Physiol Lung Cell Mol Physiol ; 279(5): L835-41, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11053017

ABSTRACT

The regulatory domain of cystic fibrosis transmembrane conductance regulator (CFTR) regulates channel activity when several serines are phosphorylated by cAMP-dependent protein kinase. To further define the functional role of individual phosphoserines, we studied CFTR containing previously studied and new serine to alanine mutations. We expressed these constructs in Fischer rat thyroid epithelia and measured transepithelial Cl(-) current. Mutation of four in vivo phosphorylation sites, Ser(660), Ser(737), Ser(795), and Ser(813) (S-Quad-A), substantially decreased cAMP-stimulated current, suggesting that these four sites account for most of the phosphorylation-dependent response. Mutation of either Ser(660) or Ser(813) alone significantly decreased current, indicating that these residues play a key role in phosphorylation-dependent stimulation. However, neither Ser(660) nor Ser(813) alone increased current to wild-type levels; both residues were required. Changing Ser(737) to alanine increased current above wild-type levels, suggesting that phosphorylation of Ser(737) may inhibit current in wild-type CFTR. These data help define the functional role of regulatory domain phosphoserines and suggest interactions between individual phosphoserines.


Subject(s)
Cystic Fibrosis Transmembrane Conductance Regulator/physiology , Epithelial Cells/physiology , Phosphoserine , Thyroid Gland/physiology , Alanine , Amino Acid Substitution , Animals , Cells, Cultured , Colforsin/pharmacology , Cystic Fibrosis Transmembrane Conductance Regulator/chemistry , Epithelial Cells/cytology , Epithelial Cells/drug effects , Membrane Potentials/drug effects , Membrane Potentials/physiology , Mutagenesis, Site-Directed , Rats , Rats, Inbred F344 , Recombinant Proteins/chemistry , Recombinant Proteins/metabolism , Serine , Thyroid Gland/cytology , Transfection
3.
J Cardiovasc Surg (Torino) ; 40(6): 861-3, 1999 Dec.
Article in English | MEDLINE | ID: mdl-10776718

ABSTRACT

A patient presented with an ischemic right forefoot. She suffered rest pain but had relief on walking and on flexing her leg. Popliteal and pedal pulses were palpable. The underlying condition was popliteal artery entrapment. Compression of the popliteal artery occurred with extension of the knee and additional contraction of the gastrocnemius muscles only and was released with flexion. Distal embolizations into all three lower leg arteries had caused acute ischemia. As the emboli had travelled through both tibial vessels very distally pedal pulses were found to be normal. Treatment was operatively by resection of a tiny lateral portion of the medial gastrocnemic tendon which crossed the artery dorsally as the vessel pierced the tendon.


Subject(s)
Forefoot, Human/blood supply , Ischemia/diagnosis , Popliteal Artery , Adolescent , Angiography , Constriction, Pathologic/surgery , Diagnosis, Differential , Embolism/diagnosis , Embolism/surgery , Female , Humans , Ischemia/surgery , Popliteal Artery/surgery , Tendons/surgery
4.
Am J Physiol ; 274(3): L305-12, 1998 03.
Article in English | MEDLINE | ID: mdl-9530164

ABSTRACT

While studying the regulation of the cystic fibrosis transmembrane conductance regulator (CFTR), we found that addition of F- to the cytosolic surface of excised, inside-out membrane patches reversibly increased Cl- current in a dose-dependent manner. Stimulation required prior phosphorylation and the presence of ATP. F- increased current even in the presence of deferoxamine, which chelates Al3+, suggesting that stimulation was not due to AlF4-. F- also stimulated current in a CFTR variant that lacked a large part of the R domain, suggesting that the effect was not mediated via this domain. Studies of single channels showed that F- increased the open-state probability by slowing channel closure from bursts of activity; the mean closed time between bursts and single-channel conductance was not altered. These results suggested that F- influenced regulation by the cytosolic domains, most likely the nucleotide-binding domains (NBDs). Consistent with this, we found that mutation of a conserved Walker lysine in NBD2 changed the relative stimulatory effect of F- compared with wild-type CFTR, whereas mutation of the Walker lysine in NBD1 had no effect. Based on these and previous data, we speculate that F- interacts with CFTR, possibly via NBD2, and slows the rate of channel closure.


Subject(s)
Cystic Fibrosis Transmembrane Conductance Regulator/metabolism , Fluorides/pharmacology , 3T3 Cells , Animals , Cystic Fibrosis Transmembrane Conductance Regulator/drug effects , Cystic Fibrosis Transmembrane Conductance Regulator/genetics , Cytosol/enzymology , Cytosol/metabolism , Enzyme Activation , Guanosine 5'-O-(3-Thiotriphosphate)/pharmacology , Kinetics , Mice , Mutagenesis, Site-Directed , Patch-Clamp Techniques , Phosphoric Monoester Hydrolases/antagonists & inhibitors
5.
Proc Natl Acad Sci U S A ; 94(20): 11055-60, 1997 Sep 30.
Article in English | MEDLINE | ID: mdl-9380758

ABSTRACT

cAMP-dependent phosphorylation activates the cystic fibrosis transmembrane conductance regulator (CFTR) in epithelia. However, the protein phosphatase (PP) that dephosphorylates and inactivates CFTR in airway and intestinal epithelia, two major sites of disease, is not certain. We found that in airway and colonic epithelia, neither okadaic acid nor FK506 prevented inactivation of CFTR when cAMP was removed. These results suggested that a phosphatase distinct from PP1, PP2A, and PP2B was responsible. Because PP2C is insensitive to these inhibitors, we tested the hypothesis that it regulates CFTR. We found that PP2Calpha is expressed in airway and T84 intestinal epithelia. To test its activity on CFTR, we generated recombinant human PP2Calpha and found that it dephosphorylated CFTR and an R domain peptide in vitro. Moreover, in cell-free patches of membrane, addition of PP2Calpha inactivated CFTR Cl- channels; reactivation required readdition of kinase. Finally, coexpression of PP2Calpha with CFTR in epithelia reduced the Cl- current and increased the rate of channel inactivation. These results suggest that PP2C may be the okadaic acid-insensitive phosphatase that regulates CFTR in human airway and T84 colonic epithelia. It has been suggested that phosphatase inhibitors could be of therapeutic value in cystic fibrosis; our data suggest that PP2C may be an important phosphatase to target.


Subject(s)
Cystic Fibrosis Transmembrane Conductance Regulator/antagonists & inhibitors , Phosphoprotein Phosphatases/metabolism , Saccharomyces cerevisiae Proteins , Animals , Cells, Cultured , Chloride Channels/antagonists & inhibitors , Cystic Fibrosis Transmembrane Conductance Regulator/metabolism , Epithelial Cells/enzymology , Epithelial Cells/metabolism , Humans , Phosphoprotein Phosphatases/genetics , Phosphoprotein Phosphatases/isolation & purification , Phosphorylation , Protein Phosphatase 2 , Protein Phosphatase 2C , Rats , Rats, Inbred F344 , Recombinant Proteins/genetics , Recombinant Proteins/isolation & purification , Recombinant Proteins/metabolism , Thyroid Gland/cytology , Thyroid Gland/metabolism , Trachea/cytology , Trachea/enzymology , Trachea/metabolism
7.
J Biol Chem ; 268(27): 20259-67, 1993 Sep 25.
Article in English | MEDLINE | ID: mdl-7690753

ABSTRACT

Phosphorylation by cAMP-dependent protein kinase (PKA) regulates the cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channel. We previously showed that in vivo PKA phosphorylated 4 serines (Ser-660, Ser-737, Ser-795, and Ser-813) within the R domain. Here we show that a mutant CFTR lacking all 4 serines can still be phosphorylated by PKA to yield an activated Cl- channel, but channel open-state probability was substantially reduced. We also observed phosphorylation and Cl- channel activity in another mutant lacking all 8 consensus PKA serines in the R domain. We were unable to identify the residual phosphorylation sites by tryptic phosphopeptide mapping. These data suggest two possible interpretations: (a) additional, as yet unidentified, phosphorylation sites within CFTR may also open the channel, or (b) the 4 serines, previously identified as in vivo PKA phosphorylation sites, are the primary regulatory sites within CFTR, but in their absence, other sites can be phosphorylated to open the channel. The additional sites are likely located within the R domain: CFTR delta R-S660A, which lacks much of the R domain (residues 708-835) and replaces Ser-660 with an alanine, was no longer regulated by PKA. Substitution of aspartate for consensus PKA phosphorylation sites in the R domain mimicked the effect of phosphorylation. Mutants containing six or more serine-to-aspartate substitutions generated Cl- channels that opened without PKA phosphorylation. These results suggest that the R domain keeps the channel closed and that phosphorylation of the R domain or insertion of the negatively charged aspartate opens the channel, perhaps by electrostatic interactions.


Subject(s)
Cystic Fibrosis/metabolism , Ion Channels/physiology , Membrane Proteins/metabolism , Membrane Proteins/physiology , Protein Kinases/metabolism , Alanine , Amino Acid Sequence , Animals , Autoradiography , Cell Line , Chloride Channels , Cystic Fibrosis Transmembrane Conductance Regulator , HeLa Cells , Humans , Ion Channel Gating , Kinetics , Membrane Proteins/genetics , Methionine/metabolism , Mutagenesis, Site-Directed , Peptide Mapping , Phosphopeptides/isolation & purification , Phosphorylation , Serine , Sulfur Radioisotopes , Transfection
8.
Cell ; 73(2): 335-46, 1993 Apr 23.
Article in English | MEDLINE | ID: mdl-7682896

ABSTRACT

Mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR) cause cystic fibrosis; the most common mutation is deletion of phenylalanine at position 508 (delta F508). We constructed STE6-CFTR chimeras with portions of the first nucleotide-binding domain (NBD1) of the yeast STE6 a-factor transporter replaced by portions of CFTR NBD1. The chimeras were functional in yeast, but mating efficiency decreased when delta F508 was introduced into NBD1. We isolated two delta F508 revertant mutations (R553M and R553Q) that restored mating; both were located within the CFTR NBD1 sequence. Introduction of these revertant mutations into human CFTR partially corrected the processing and Cl- channel gating defects caused by the delta F508 mutation. These results suggest that the NBD1s of CFTR and STE6 share a similar structure and function and that, in CFTR, the regions containing F508 and R553 interact. They also indicate that the abnormal conformation produced by delta F508 can be partially corrected by additional alterations in the protein.


Subject(s)
ATP-Binding Cassette Transporters , Fungal Proteins/genetics , Glycoproteins , Ion Channels/genetics , Membrane Proteins/genetics , Saccharomyces cerevisiae Proteins , Adenosine Triphosphatases/metabolism , Amino Acid Sequence , Anions/metabolism , Base Sequence , Biological Transport , Cell Compartmentation , Cystic Fibrosis/physiopathology , Cystic Fibrosis Transmembrane Conductance Regulator , Genes, Suppressor , Genetic Complementation Test , HeLa Cells , Humans , Ion Channel Gating , Ion Channels/metabolism , Molecular Sequence Data , Nucleotides/metabolism , Oligodeoxyribonucleotides/chemistry , Protein Kinases/metabolism , Protein Processing, Post-Translational , Recombinant Fusion Proteins/genetics , Saccharomyces cerevisiae/genetics , Structure-Activity Relationship , Transfection
9.
J Biol Chem ; 268(3): 2037-47, 1993 Jan 25.
Article in English | MEDLINE | ID: mdl-7678414

ABSTRACT

Cystic fibrosis transmembrane conductance regulator (CFTR) is a regulated Cl- channel; in secretory epithelia, it is located in the apical membrane where it regulates transepithelial Cl- secretion. Previous studies have shown that cAMP-dependent protein kinase (PKA) can phosphorylate and activate CFTR Cl- channels. We asked whether other kinases would phosphorylate CFTR in vitro and activate CFTR Cl- channels in excised, inside-out patches of membrane from NIH 3T3 fibroblasts stably expressing recombinant CFTR. We found that both Ca(2+)-independent and Ca(2+)-dependent isoforms of protein kinase C (PKC) activated the CFTR Cl- channel. Consistent with this finding, PKC also phosphorylated CFTR in vitro. In contrast, the multifunctional Ca2+/calmodulin-dependent protein kinase failed to either activate or to phosphorylate CFTR Cl- channels, suggesting that this enzyme has no direct effect on CFTR. We found that cGMP-dependent protein kinase (cGK) (purified from bovine lung) phosphorylated CFTR in vitro. However, cGMP failed to increase the apical membrane Cl- permeability in human airway epithelia, and addition of cGMP, ATP, and cGK failed to activate CFTR Cl- channels. These results suggest that if cGK phosphorylates CFTR in vivo, it does so at sites not involved in CFTR Cl- channel activation. Because cAMP-dependent activation of CFTR Cl- channels and Cl- secretion in intact cells is reversible, we asked whether specific phosphatases can dephosphorylate and inactivate CFTR Cl- channels. Addition of protein phosphatase 2A (PP2A) decreased PKA-activated current by 67% within 10 min. The phosphatase inhibitor calyculin-A blocked the effect of PP2A. In contrast, neither protein phosphatases 1, 2B, nor two preparations of alkaline phosphatase inactivated PKA-phosphorylated CFTR Cl- channels. The effects of protein phosphatases on CFTR function were paralleled by their ability to dephosphorylate CFTR in vitro. Our data indicate that CFTR Cl- channels can be phosphorylated and activated by PKA as well as by Ca(2+)-dependent and Ca(2+)-independent isoforms of PKC and can be dephosphorylated and thus inactivated by PP2A.


Subject(s)
Cystic Fibrosis , Membrane Proteins/physiology , Phosphoprotein Phosphatases/metabolism , Protein Kinases/metabolism , 3T3 Cells , Animals , Calcium/pharmacology , Calmodulin/pharmacology , Cell Membrane/physiology , Chloride Channels , Chlorides/metabolism , Cyclic AMP/pharmacology , Cyclic GMP/pharmacology , Cystic Fibrosis Transmembrane Conductance Regulator , Humans , Isoenzymes/metabolism , Mice , Phosphorylation , Protein Kinase C/metabolism , Protein Phosphatase 2 , Recombinant Proteins/metabolism
10.
Am J Physiol ; 263(1 Pt 1): L1-14, 1992 Jul.
Article in English | MEDLINE | ID: mdl-1322048

ABSTRACT

Cl- channels located in the apical membrane of secretory epithelia play a key role in epithelial fluid and electrolyte transport. Dysfunction of one of these channels, cystic fibrosis transmembrane conductance regulator (CFTR), causes the genetic disease cystic fibrosis (CF). We review here the properties and regulation of the different types of Cl- channels that have been reported in airway and intestinal epithelia. We begin by describing the properties of the CFTR Cl- channel and then use those properties as a point of reference. We focused particularly on the evidence that localizes specific types of Cl- channel to the apical membrane. With that background, we assess the biological function of various Cl- channels in airway and intestinal epithelia.


Subject(s)
Cystic Fibrosis/metabolism , Intestinal Mucosa/metabolism , Membrane Proteins/metabolism , Animals , Calcium/physiology , Cell Membrane/metabolism , Chloride Channels , Chlorides/metabolism , Cyclic AMP/physiology , Electrophysiology , Epithelium/metabolism , Humans , Membrane Proteins/physiology , Reference Values
12.
Thorax ; 47(2): 134-5, 1992 Feb.
Article in English | MEDLINE | ID: mdl-1549822

ABSTRACT

Chylothorax is an unusual complication of sclerotherapy for oesophageal varices. A patient is described in whom a massive chylous effusion followed sclerotherapy with repeated injections of 1.5% sodium tetradecyl sulphate. The thoracic duct traverses the posterior mediastinum in close proximity to the oesophagus, and may be disrupted by injections at mid oesophageal level.


Subject(s)
Chylothorax/etiology , Esophageal and Gastric Varices/therapy , Sclerotherapy/adverse effects , Female , Humans , Middle Aged
13.
Cell ; 67(4): 775-84, 1991 Nov 15.
Article in English | MEDLINE | ID: mdl-1718606

ABSTRACT

The CFTR Cl- channel contains two predicted nucleotide-binding domains (NBD1 and NBD2); therefore, we examined the effect of ATP on channel activity. Once phosphorylated by cAMP-dependent protein kinase (PKA), channels required cytosolic ATP to open. Activation occurred by a PKA-independent mechanism. ATP gamma S substituted for ATP in PKA phosphorylation, but it did not open the channel. Several hydrolyzable nucleotides (ATP greater than GTP greater than ITP approximately UTP greater than CTP) reversibly activated phosphorylated channels, but nonhydrolyzable analogs and Mg(2+)-free ATP did not. Studies of CFTR mutants indicated that ATP controls channel activity independent of the R domain and suggested that hydrolysis of ATP by NBD1 may be sufficient for channel opening. The finding that nucleoside triphosphates regulate CFTR begins to explain why CF-associated mutations in the NBDs block Cl- channel function.


Subject(s)
Ion Channel Gating , Membrane Proteins/physiology , Nucleotides/physiology , Adenosine Triphosphate/analogs & derivatives , Adenosine Triphosphate/pharmacology , Adenosine Triphosphate/physiology , Animals , Binding Sites , Chloride Channels , Cystic Fibrosis Transmembrane Conductance Regulator , DNA Mutational Analysis , Electric Conductivity , Humans , In Vitro Techniques , Mice , Phosphorylation , Protein Kinases/physiology , Structure-Activity Relationship
14.
J Clin Invest ; 88(4): 1422-31, 1991 Oct.
Article in English | MEDLINE | ID: mdl-1717515

ABSTRACT

Cystic fibrosis transmembrane conductance regulator (CFTR) generates cAMP-regulated Cl- channels; mutations in CFTR cause defective Cl- channel function in cystic fibrosis epithelia. We used the patch-clamp technique to determine the single channel properties of Cl- channels in cell expressing recombinant CFTR. In cell-attached patches, an increase in cellular cAMP reversibly activated low conductance Cl- channels. cAMP-dependent regulation is due to phosphorylation, because the catalytic subunit of cAMP-dependent protein kinase plus ATP reversibly activated the channel in excised, cell-free patches of membrane. In symmetrical Cl- solutions, the channel had a channel conductance of 10.4 +/- 0.2 (n = 7) pS and a linear current-voltage relation. The channel was more permeable to Cl- than to I- and showed no appreciable time-dependent voltage effects. These biophysical properties are consistent with macroscopic studies of Cl- channels in single cells expressing CFTR and in the apical membrane of secretory epithelia. Identification of the single channel characteristics of CFTR-generated channels allows further studies of their regulation and the mechanism of ion permeation.


Subject(s)
Cystic Fibrosis/metabolism , Membrane Proteins/physiology , Adenosine Triphosphate/pharmacology , Animals , Chloride Channels , Cystic Fibrosis Transmembrane Conductance Regulator , Humans , Mice , Protein Kinases/pharmacology
15.
Hosp Pract (Off Ed) ; 26(3): 53-9, 1991 Mar 15.
Article in English | MEDLINE | ID: mdl-1706347

ABSTRACT

The crucial physiologic role of such transport is illustrated by cystic fibrosis. In that lethal genetic disease, transepithelial sodium absorption and chloride secretion are respectively increased and decreased, and pulmonary mucus is dehydrated. Mechanisms that regulate normal sodium and chloride movement are discussed, as are the derangements in cystic fibrosis.


Subject(s)
Chlorides/metabolism , Cystic Fibrosis/physiopathology , Lung/physiology , Potassium Channels/physiology , Sodium Channels/physiology , Amiloride/pharmacology , Cystic Fibrosis/enzymology , Cystic Fibrosis/metabolism , Diuretics/pharmacology , Humans , Ion Channels/drug effects , Ion Channels/physiology , Lung/anatomy & histology , Lung/enzymology , Lung/metabolism , Ouabain/pharmacology , Potassium Channels/drug effects , Sodium Channels/drug effects , Sodium-Potassium-Exchanging ATPase/metabolism
16.
Chest ; 97(3): 731-5, 1990 Mar.
Article in English | MEDLINE | ID: mdl-2306975

ABSTRACT

We retrospectively investigated if the clinical course of complicated parapneumonic effusions was altered by treatment with immediate drainage plus antibiotics vs antibiotics alone. The two groups of patients had no significant differences in age, duration of symptoms prior to hospitalization, initial maximum temperature, WBC count, or characteristics of the pleural fluid. There were no differences in the duration of hospitalization, fever, elevated WBC count, intravenous antibiotic therapy, or the time for roentgenographic resolution of the effusions. There was one death in each group. The infection of the pleural space resolved in 13 of 16 patients treated with antibiotics alone. No recurrence of the infection of the pleural space occurred in these patients. Antibiotics alone were not sufficient in two cases which eventually required chest tube drainage. Therefore, not all complicated parapneumonic effusions require drainage. A prospective study is required to determine if chest tube drainage should be part of the initial management of complicated parapneumonic effusions.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Drainage , Empyema/drug therapy , Pleural Effusion/drug therapy , Anti-Bacterial Agents/administration & dosage , Combined Modality Therapy , Empyema/surgery , Fever , Hospitalization , Humans , Injections, Intravenous , Leukocyte Count , Middle Aged , Pleural Effusion/surgery , Pneumonia/complications , Retrospective Studies , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...